title: Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders.
authors: Laboratory of Cerebrovascular Biology, Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, University Hospital, Uppsala University, SE-75185, Uppsala, Sweden. Sharma@surgsci.uu.se.
authors: Hari S
authors: HS
authors: Sharma
authors: Stephen D
authors: SD
authors: Skaper
authors: Aruna
authors: A
authors: Sharma
mesh_terms: D002493:Central Nervous System Diseases / Q000188:drug therapy*; D018494:Histamine Agents / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*
chemical_list: D018494:Histamine Agents; D018696:Neuroprotective Agents